These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15969935)

  • 1. Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern.
    O'Callaghan C; White J; Jackson J; Barry PW; Kantar A
    J Pharm Pharmacol; 2005 Jun; 57(6):787-90. PubMed ID: 15969935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The output of flunisolide from different nebulisers.
    O'Callaghan C; White J; Jackson J; Barry P; Kantar A
    J Pharm Pharmacol; 2002 Apr; 54(4):565-9. PubMed ID: 11999135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulisation of corticosteroid suspensions and solutions with a beta(2) agonist.
    O'Callaghan CL; White JA; Jackson JM; Barry PW; Kantar A
    J Pharm Pharmacol; 2008 May; 60(5):601-5. PubMed ID: 18416936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
    Berg EB; Picard RJ
    Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro analysis of the output of budesonide from different nebulizers.
    Barry PW; O'Callaghan C
    J Allergy Clin Immunol; 1999 Dec; 104(6):1168-73. PubMed ID: 10588997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
    Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
    Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug output from nebulizers is dependent on the method of measurement.
    Barry PW; O'Callaghan C
    Eur Respir J; 1998 Aug; 12(2):463-6. PubMed ID: 9727802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of equipment dead space and pediatric breathing patterns on inhaled mass of nebulized budesonide.
    Nikander K; Denyer J; Smaldone GC
    J Aerosol Med; 1999; 12(2):67-73. PubMed ID: 10539709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.
    Nikander K; Turpeinen M; Wollmer P
    J Aerosol Med; 1999; 12(2):47-53. PubMed ID: 10539706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulization of a suspension of budesonide and a solution of terbutaline into a neonatal ventilator circuit.
    Turpeinen M; Nikander K
    Respir Care; 2001 Jan; 46(1):43-8. PubMed ID: 11175237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
    Johnson JC; Waldrep JC; Guo J; Dhand R
    Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The output of budesonide from spacer devices assessed under simulated breathing conditions.
    Barry PW; O'Callaghan C
    J Allergy Clin Immunol; 1999 Dec; 104(6):1205-10. PubMed ID: 10589002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of the circulaire and AeroTee to a traditional nebulizer T-piece with corrugated tubing.
    Piper SD
    Respir Care; 2000 Mar; 45(3):313-9. PubMed ID: 10771800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro study to investigate the use of a breath-actuated, small-volume, pneumatic nebulizer for the delivery of methacholine chloride bronchoprovocation agent.
    Mitchell JP; Nagel MW; Bates SL; Doyle CC
    Respir Care; 2003 Jan; 48(1):46-51. PubMed ID: 12556261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U; Marschall K; Fyrnys B; Wedel M
    Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.